India · Delayed Price · Currency is INR Prism Medico and Pharmacy Statistics
Total Valuation
BOM:512217 has a market cap or net worth of INR 152.86 million. The enterprise value is 152.21 million.
| Market Cap | 152.86M |
| Enterprise Value | 152.21M |
Important Dates
The next estimated earnings date is Tuesday, May 26, 2026.
| Earnings Date | May 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:512217 has 6.06 million shares outstanding. The number of shares has increased by 39.58% in one year.
| Current Share Class | 6.06M |
| Shares Outstanding | 6.06M |
| Shares Change (YoY) | +39.58% |
| Shares Change (QoQ) | +10.61% |
| Owned by Insiders (%) | 28.86% |
| Owned by Institutions (%) | 2.37% |
| Float | 2.80M |
Valuation Ratios
The trailing PE ratio is 25.45.
| PE Ratio | 25.45 |
| Forward PE | n/a |
| PS Ratio | 6.84 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 25.34 |
| EV / Sales | 6.81 |
| EV / EBITDA | 26.52 |
| EV / EBIT | 26.67 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 219.46 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -0.49% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.77% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -255,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +115.10% in the last 52 weeks. The beta is 0.46, so BOM:512217's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +115.10% |
| 50-Day Moving Average | 21.61 |
| 200-Day Moving Average | 18.52 |
| Relative Strength Index (RSI) | 53.37 |
| Average Volume (20 Days) | 103,599 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:512217 had revenue of INR 22.35 million and earned 6.01 million in profits. Earnings per share was 0.01.
| Revenue | 22.35M |
| Gross Profit | 8.70M |
| Operating Income | 5.71M |
| Pretax Income | 5.75M |
| Net Income | 6.01M |
| EBITDA | 5.74M |
| EBIT | 5.71M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | n/a |
| Book Value Per Share | n/a |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 33,750 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 38.92%, with operating and profit margins of 25.53% and 26.87%.
| Gross Margin | 38.92% |
| Operating Margin | 25.53% |
| Pretax Margin | 25.73% |
| Profit Margin | 26.87% |
| EBITDA Margin | 25.68% |
| EBIT Margin | 25.53% |
| FCF Margin | n/a |
Dividends & Yields
BOM:512217 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -39.58% |
| Shareholder Yield | -39.58% |
| Earnings Yield | 3.93% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |